NCT06929247View on ClinicalTrials.gov

Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years.

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Pulpitis - Irreversible
Interventions
PROCEDURE

Pulpotomy using Neoputty Mineral Trioxide Aggregate

Pulpotomy (Test Group): Removal of coronal pulp followed by Neoputty MTA placement and restoration.

PROCEDURE

single visit pulpectomy using metapex

pulpectomy: removal of radicular pulp followed by metapex placement and final restoration

All Listed Sponsors
lead

Mohamed Nashaat Mohamed

OTHER

NCT06929247 - Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years. | Biotech Hunter | Biotech Hunter